Multiple primary melanoma: two-year results from a population-based study

Archives of Dermatology
Linda Titus-ErnstoffMarc S Ernstoff

Abstract

To assess the frequency of occurrence and risk factors for multiple primary melanoma. Population-based, case-control study. New Hampshire. Three-hundred fifty-four New Hampshire residents with a confirmed first diagnosis of cutaneous melanoma. Diagnosis of a subsequent primary cutaneous melanoma. An additional melanoma occurred in 27 individuals (8%) within 2 years of their initial diagnosis, including 20 (6%) within the first postdiagnosis year. In 9 (33%) of these 27 cases, at least 1 subsequent melanoma was deeper than the first tumor. The 27 individuals with a subsequent melanoma diagnosis were classified as "cases" and were compared on the basis of risk factors to the 327 "controls" with a single melanoma diagnosis. The data indicate an inverse relation of risk of multiple primary melanomas with multiple blistering sunburns (P = .01 for the trend); the odds ratio (OR) was 0.32 (95% confidence interval [CI], 0.11-0.93) for 2 or more sunburns compared with none. The number of atypical moles was significantly related to increased risk (P = .004 for the trend). The presence of 3 or more atypical moles compared with none was associated with more than a 4-fold risk of multiple primary melanomas (OR, 4.29; 95% CI, 1.51-12.16). Ad...Continue Reading

Citations

Mar 17, 2010·Archives of Dermatology·Porcia T BradfordMargaret A Tucker
Mar 27, 2013·Nature Reviews. Clinical Oncology·Lois B TravisAndrea K Ng
Sep 11, 2013·Australian Health Review : a Publication of the Australian Hospital Association·Drew CarterSusan Neuhaus
Jul 10, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R DummerG Pentheroudakis
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R DummerUNKNOWN ESMO Guidelines Working Group
Sep 14, 2011·Annals of Surgical Oncology·Rajmohan MuraliUNKNOWN GEM Study Group
Dec 24, 2014·Journal of Skin Cancer·Janine MitchellTaryn Bessen
Oct 15, 2010·The Journal of Investigative Dermatology·Victor SiskindDavid C Whiteman
Mar 14, 2007·Mayo Clinic Proceedings·Svetomir N MarkovicUNKNOWN Melanoma Study Group of the Mayo Clinic Cancer Center
Aug 26, 2015·American Journal of Surgery·Adam C KrajewskiTina J Hieken
Mar 14, 2009·Journal of Cutaneous Pathology·James T EdingerDrazen M Jukic
Aug 9, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·P SavoiaM G Bernengo
Jan 17, 2012·Cancer·Charlotte HwaJennifer A Stein
Feb 5, 2013·The British Journal of Dermatology·E MoscarellaG Argenziano
Dec 12, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·A VecchiatoC R Rossi
Mar 14, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·F NeczyporenkoB Richert
May 15, 2010·International Journal of Dermatology·Estee L PsatyAshfaq A Marghoob
Aug 25, 2015·Journal of the American Academy of Dermatology·Megan M MooreMaryam M Asgari
Dec 11, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·R J T van der LeestT Nijsten
Sep 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R DummerUNKNOWN ESMO Guidelines Committee
Jan 1, 2009·Dermatology Research and Practice·Haike M J van der VeldenMarie-Jeanne P Gerritsen
Apr 10, 2007·Mayo Clinic Proceedings·Svetomir N MarkovicUNKNOWN Melanoma Study Group of Mayo Clinic Cancer Center
Jun 18, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonis Valachis, Gustav J Ullenhag
Apr 1, 2018·Pigment Cell & Melanoma Research·Nikki R AdlerVictoria J Mar
Oct 1, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O MichielinUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Mar 13, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·N Pastor-TomásE Nagore
Jun 30, 2009·Annals of the Royal College of Surgeons of England·R A PearlA O Grobbelaar
Oct 31, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·K AzarjanaD Pjanova
Sep 7, 2016·The British Journal of Dermatology·M S SchuurmanK K H Aben
Dec 20, 2018·JAMA Dermatology·Christoph MüllerIchiro Okamoto
Jun 27, 2019·JAMA Dermatology·Mary-Ann El SharouniPaul J van Diest
Jun 25, 2020·Journal of the National Cancer Institute·Hildur HelgadottirHåkan Olsson
Nov 11, 2020·Cancer·Lilit KarapetyanJohn M Kirkwood
Sep 10, 2019·Journal of the American Academy of Dermatology·Aimilios LallasDimitrios Ioannides
Mar 7, 2021·International Journal of Environmental Research and Public Health·Nevio DubbiniAntonella Romanini
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O MichielinUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the European Academy of Dermatology and Venereology : JEADV
A M ManganoniP G Calzavara Pinton
Journal of the American Academy of Dermatology
T M JohnsonL Lowe
Archives of Dermatology
Anna Doubrovsky, Scott W Menzies
© 2022 Meta ULC. All rights reserved